MFS
SAGE

MSI Financial Services’s Sage Therapeutics SAGE Stock Holding History

MSI Financial Services’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-300
Closed -$9K – 3998
2016
Q2 		$9K Sell
300
-89
-23% -$2.97K ﹤0.01% 2836
2016
Q1 		$12K Hold
389
– – ﹤0.01% 2638
2015
Q4 		$23K Buy
389
+372
+2,188% +$18.4K ﹤0.01% 2229
2015
Q3 		$1K Buy
+17
New +$1.05K ﹤0.01% 3004

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MSI Financial Services's SAGE Position: Q3 2016 in Review

MSI Financial Services sold out of Sage Therapeutics (SAGE) in Q3 2016, closing a stake of 300 shares — an estimated $9K sold.

MSI Financial Services first reported a position in SAGE in Q3 2015 and held it in 4 quarters. The position peaked at $23K in Q4 2015. 153 funds tracked by Wall St. Rank hold SAGE as of Q3 2016.

  • MSI Financial Services reported no remaining Sage Therapeutics position as of Q3 2016 after selling out during the quarter.
  • MSI Financial Services sold 300 Sage Therapeutics shares in Q3 2016, an estimated $9K.
  • MSI Financial Services first reported a position in Sage Therapeutics in Q3 2015 and held it in 4 quarters.
  • MSI Financial Services's Sage Therapeutics position peaked at $23K in Q4 2015.
  • 153 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2016.

Based on MSI Financial Services's 13F filing for Q3 2016, filed 13 Oct 2016.